Asthma inhalers and climate change

Criterion

Assessment

More information

Process

1.Has information available about the updating policy.

Met

See methodology document section 9

2.Provides an indication that the shared decision aid is underpinned by evidence.

Met

About this patient decision aid'

3.Provides information about the levels of uncertainty around event or outcome probabilities, e.g. by giving a range or by using phases such as ‘our best estimate is.

Met

Most people with asthma are able to do this, but not everyone can

4.An equality impact assessment has been carried out to identify impact on inequalities groups.

Met

Assumed - developed in line with NICE equality scheme' implies EQIA

Content

1.Provides a production or publication date.

Met

Sep-22

2. Provides information about country of publication.

Met

UK

3. Describes the health condition or issue for which the decision is required.

Met

Carbon footprint of inhalers

4.States the decision that needs to be considered.

Met

What are my options section

5. Provides clear information about the potential consequences, benefits and harms of each option

Met

Effects on both asthma and climate change

6.Displays and frames options in a consistent, balanced and impartial way - for example, using the same sized font and neutral language

Met

Summary table then more detailed text mirroring that content

7. Uses everyday language that is widely understood, or simpler language where necessary.

Not met (reading age over 11 for direct patient use)

Your direct input has an average reading ease of about 40 of 100. It should be easily understood by 18 to 19 year olds.

8. Shows that effort has been made to present quantitative information about risks, benefits, chance and uncertainty in a way that is understandable to people with low levels of numeracy

Met

See figure on carbon footprint of inhalers

 9. Is presented in a digital format that complies with accessibility standards

Met

Complies with W3C AAA standard.